Search Results - R. Zambello
- Showing 1 - 18 results of 18
-
1
P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH by S. Manni, Z. Spinello, M. Pesavento, A. Fregnani, L. Saggin, L. Quotti Tubi, G. Scapinello, F. Vianello, R. Zambello, C. Gurrieri, G. Semenzato, L. Trentin, F. Piazza
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P605: T-CELL PROLYMPHOCYTIC LEUKEMIA: MOLECULAR CHARACTERIZATION OF A COHORT OF 18 PATIENTS AND EVALUATION OF BORTEZOMIB AS A POSSIBLE THERAPEUTIC STRATEGY by V. R. Gasparini, A. Martines, G. Barilà, A. Teramo, G. Calabretto, C. Vicenzetto, S. Carraro, V. Trimarco, L. Trentin, M. Facco, G. Semenzato, L. Bonaldi, R. Zambello
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P600: HIGH-DEPTH RNA-SEQUENCING IDENTIFIES CD8+ STAT3 MUTATED T-LGLL PATIENTS AS A DISTINCT BIOLOGICAL ENTITY WITHIN THE DISEASE HETEROGENEITY by G. Calabretto, A. Binatti, A. Teramo, G. Barilà, A. Buratin, V. R. Gasparini, C. Vicenzetto, E. Gaffo, V. Trimarco, L. Trentin, M. Facco, F. Vianello, G. Semenzato, R. Zambello, S. Bortoluzzi
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE by L. Massarotti, A. Branca, L. Pavan, A. Maroccia, C.A. Cavarretta, V. Ruocco, I. Zatta, G. Scapinello, F. Piazza, F. D’Amore, F. Lessi, C. Gurrieri, R. Zambello, L. Trentin, T. Berno
Published in HemaSphere (2023-05-01)Get full text
Article -
5
P02: PROGNOSTIC STRATIFICATION OF STANDARD RISK MULTIPLE MYELOMA DEFINED BY REVISED ISS by G Barilà, L Bonaldi, A Martines, A Pascarella, S Vedovato, C Clissa, N Macrì, A Bonalumi, L Pavan, M Tinelli, S Nalio, A Teramo, G Calabretto, VR Gasparini, M Krampera, R Bassan, R Zambello
Published in HemaSphere (2022-04-01)Get full text
Article -
6
P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38... by M. Offidani, S. Morè, M. Cavo, D. Derudas, F. Di Raimondo, A. Cuneo, L. Baldini, R. Della Pepa, M. Musso, M. Boccadoro, P. Musto, A. Belotti, F. Fioritoni, N. Di Renzo, A. Mele, B. Gamberi, L. De Paoli, R. Zambello, S. Grammatico, M. Brociner, F. Fazio, M. T. Petrucci
Published in HemaSphere (2023-05-01)Get full text
Article -
7
P015 | FEATURES AND OUTCOMES OF ASYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA IN RELATION TO BONE MARROW INFILTRATION: AN ITALIAN UNIVERSITY HOSPITAL ANALYSIS by N. Danesin, G. Leone, M. Carraro, G. Scapinello, M. D’antiga, A. Cellini, F. Angotzi, A. Serafin, A. Bevilacqua, S. Zoletto, A. Martines, L. Bonaldi, C. Gurrieri, F. Scarmozzino, A. Branca, T. Berno, R. Zambello, F. Vianello, C. Briani, S. Manni, M. Pizzi, A. Visentin, L. Trentin, F. Piazza
Published in Haematologica (2025-09-01)Get full text
Article -
8
P49 A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHER... by A. Furlan, M. Cea, R. Zambello, L. Pavan, M Galli, C. Clissa, S. Mangiacavalli, A. Cafro, S. Girlanda, F. Patriarca, C. Minotto, G. Bertoldero, G. Barilà, A. Pascarella, A. Lico, R. Paolini, N. Rabassi, N. Pescosta, M. Porrazzo, G. De Sabbata, A. Pompa, G. Bega, S. Cavallin, F. Guidotti, G. Semenzato, C. Zaina, F. Gherlinzoni
Published in HemaSphere (2023-05-01)Get full text
Article -
9
P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED P... by A. Larocca, M. D’Agostino, N. Giuliani, E. Antonioli, R. Zambello, S. Ronconi, I. D. Vincelli, F. Ciceri, A. P. Falcone, M. Michieli, F. Cattel, A. Capra, M. Grasso, A. M. Cafro, F. Bonello, R. Floris, M. Offidani, E. Sciorsi, G. Pietrantuono, P. Curci, F. Patriarca, M. Cavo, S. Mangiacavalli, G. Benevolo, A. Evangelista, G. Ciccone, M. Boccadoro, B. Bruno, S. Bringhen
Published in HemaSphere (2023-05-01)Get full text
Article -
10
P169 | REAL-WORLD MINIMAL RESIDUAL DISEASE ANALYSIS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA PATIENTS TREATED WITH DARA-VMP VS. DARA-RD IN THE RANDOMIZED PHASE IV REAL MM TRIAL by L. Cani, M. D’Agostino, R. Ria, S. Mangiacavalli, G. Benevolo, N. Giuliani, R. Zambello, S. Terlizzi, K. Mancuso, A.P. Falcone, I. D. Vincelli, A. Liso, F. Patriarca, A. Casson, S. Bringhen, ; A. Evangelista, E. Sciorsi, P. Curci, F. Vassallo, G. Margiotta-Casaluci, M.T. Petrucci, D. Mannina, P. Bertazzoni, I. Attucci, M. Offidani, F. Cattel, G. Ciccone, B. Bruno, M. Boccadoro, A. Larocca
Published in Haematologica (2025-09-01)Get full text
Article -
11
P159 | CIRCULATING TUMOUR CELLS QUANTIFICATION IN NEWLY-DIAGNOSED TRANSPLANT INELIGIBLE REAL WORLD MULTIPLE MYELOMA PATIENTS: COMPARISON OF SINGLE PLATFORM FLOW CYTOMETRY VS. NEXT... by E. Saraci, A. Larocca, R. Ria, S. Mangiacavalli, G. Benevolo, N. Giuliani, R. Zambello, A. Belotti, I. Rizzello, A.P. Falcone, I. D. Vincelli, M. Michieli, S. Ronconi, P. Tosi, A. Conconi, A. Allegra, M.M. Cavalli, M. Scaldaferri, I. Fedele, M. Burdisso, B. Salono, M. Martelli, D. Mannina, A.M. Cafro, E. Antonioli, S. Morè, M. Boccadoro, B. Bruno, S. Bringhen, M. D’agostino
Published in Haematologica (2025-09-01)Get full text
Article -
12
P029 | SECONDARY HYPOGAMMAGLOBULINEMIA IN NON-HODGKIN LYMPHOMAS: INCIDENCE, RISK FACTORS, AND CLINICAL IMPACT by N. Danesin, T. Stefani, P. Bez, V. Carabotta, S. Zoletto, G. Binotto, I. Gianesello, J. Ceccato, G. Gualtiero, G. Leone, M. Carraro, G. Scapinello, M. D’antiga, A. Cellini, F. Angotzi, L. Massarotti, V. Ruocco, I. Zatta, X. Hu, A. Serafin, A. Bevilacqua, F. Mazzetto, A. Calleri, L. Pavan, F. D’amore, R. Zambello, A. Visentin, L. Trentin, F. Piazza, M. Piazza, R. Scarpa, F. Cinetto, F. Vianello
Published in Haematologica (2025-09-01)Get full text
Article -
13
C061 | CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL by F. Gay, G. Bertuglia, D. Rota-Scalabrini, A. Belotti, L. Paris, M. Cea, F. Patriarca, M. D'agostino, M. Gentile, M. Luppi, G. De Sabbata, S. Palmieri, G. Pietrantuono, A.M. Liberati, R. Bassan, F. Monaco, P. Tosi, O. Annibali, F. Pisani, P. Galieni, N. Pescosta, L. De Rosa, R. Zambello, M.T. Petrucci, P. Corradini, M. Offidani, B. Bruno, M. Boccadoro, E. Zamagni, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
14
P20 LENALIDOMIDE MAINTENANCE AFTER VTD INDUCTION AND AUTOLOGOUS STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A REAL-LIFE STUDY INCLUDING 389 PATIENTS by G. Barilà, A. Pascarella, C. Conticello, R. Mina, C. Marcon, F. Fazio, C. Cartia, G. Buda, S. Pilerci, S. Rocchi, A. Maroccia, N. Sgherza, M. Porrazzo, N. Pescosta, A. Furlan, E. Scomazzon, G. Mele, M. Gentile, M.L. Del Giudice, G. Schininà, L. Pavan, G. De Cicco, A. Casson, C. Lisi, E. Antonioli, S. Mangiacavalli, P. Musto, F. Gay, E. Zamagni, M.T. Petrucci, F. Di Raimondo, F. Patriarca, R. Bassan, R. Zambello
Published in HemaSphere (2023-05-01)Get full text
Article -
15
DP117 | THE TREATMENT OF TRANSPLANT ELIGIBLE PRIMARY PLASMA CELL LEUKEMIA PATIENTS: AN ITALIAN REAL-LIFE STUDY by G. Barilà, L. Pavan, F. Fazio, C. Liberatore, N. Sgherza, S. Morè, G. Vianello, C. S. Cartia, S. Oliva, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, L. Pettine, B. Rossini, F. Guidotti, S. Vedovato, F. Rezzonico, R. Della Pepa, P. Boggione, D. Derudas, D. Nappi, F. Farina, F. Vassallo, B. Gamberi, S. Mangiacavalli, N. Giuliani, M. Galli, A. Tosetto, E. Zamagni, F. Patriarca, M. Offidani, M. T. Petrucci, R. Zambello, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
16
DP040 | NOVEL GENETIC VARIANTS AND OLIGOGENIC MECHANISMS IN IDIOPATHIC ERYTHROCYTOSIS: A TARGETED NEXT-GENERATION SEQUENCING APPROACH by A. Giannella, A. Magrini, G. Ceolotto, S. Zoletto, V. Carabotta, G. Binotto, I. Gianesello, M. Piazza, J. Ceccato, G. Gualtiero, N. Danesin, G. Leone, M. Carraro, G. Scapinello, M. D’antiga, A. Cellini, F. Angotzi, L. Massarotti, V. Ruocco, I. Zatta, X. Hu, A. Serafin, A. Bevilacqua, F. Mazzetto, A. Calleri, L. Pavan, C. Gurrieri, F. Lessi, C.A. Cavarretta, A. Branca, T. Berno, F. D’amore, S. Pravato, R. Zambello, A. Visentin, L. Trentin, F. Piazza, F. Vianello
Published in Haematologica (2025-09-01)Get full text
Article -
17
C063 | ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE VERSUS DARATUMUMAB-POMALIDOMIDE-DEXAMETHASONE IN PATIENTS PROGRESSING AFTER LENALIDOMIDE MAINTENANCE: AN ITALIAN REAL-LIFE STUDY by V. Ruocco, C. Liberatore, E. Olivari, M. Tinelli, F. Fazio, E. Favero, C.S. Cartia, N. Sgherza, C. Conticello, R. Mina, M. Gherardini, G. Mele, M. Gentile, A. Furlan, M. Arangio Febbo, O. Annibali, B. Rossini, E. Scomazzon, F. Monaco, E.A. Martino, C. De Magistris, F. Fioritoni, A.M. Cafro, S. Pezzatti, R. Della Pepa, P. Boggione, G. Pietrantuono, V. Tomarchio, F. Vassallo, M.L. Pioltelli, F. Pisani, A. Cagnetta, G. Buda, E. Antonioli, L. Paris, A. Tosetto, P. Musto, E. Zamagni, F. Patriarca, S. Mangiacavalli, R. Zambello, M. Offidani
Published in Haematologica (2025-09-01)Get full text
Article -
18
PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLL... by A. Bruzzese, D. Derudas, M. Galli, E. A. Martino, S. Rocco, C. Conticello, C. Califano, N. Giuliani, S. Mangicavalli, G. Farina, A. Lombardo, M. Brunori, E. Rossi, E. Antonioli, R. Ria, R. Zambello, N. Di Renzo, G. Mele, G. Marcacci, G. Pietrantuono, G. Palumbo, N. Cascavilla, C. Cerchione, A. Belotti, C. Criscuolo, G. Uccello, P. Curci, E. Vigna, F. Mendicino, E. Iaccino, S. Mimmi, C. Botta, D. Vincelli, N. Sgherza, A. Bonalumi, L. Cupelli, R. Stocchi, M. Martino, S. Ballanti, D. Gangemi, A. Gagliardi, B. Gamberi, A. Pompa, G. Tripepi, F. Frigeri, U. Consoli, S. Bringhen, E. Zamagni, F. Patriarca, V. De Stefano, F. Di Raimondo, S. Palmieri, M. T. Petrucci, M. Offidani, P. Musto, M. Boccadoro, M. Cavo, A. Neri, F. Morabito, M. Gentile
Published in HemaSphere (2022-06-01)Get full text
Article
